Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| uniQure N.V.QURE · Entity 4162 | Director · CEO, Managing Director | July 02, 2026 | July 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
uniQure N.V.
Report date July 02, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 519,227 |
Ending reported balance
After 2026-07-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-07-02 · Exercise / conversion · Acquired 21,082 · Balance 540,309 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Row 2 · 2026-07-02 · Sale · Disposed 9,200 · Balance 531,109 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.10 to $44.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-07-02 · Sale · Disposed 4,282 · Balance 526,827 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-07-02 · Sale · Disposed 7,600 · Balance 519,227 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.48 to $46.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.39 · Expires 2028-01-26 | Direct | 0 |
Reported balance
After 2026-07-02 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-07-02 · Exercise / conversion · Disposed 21,082 · Balance 0 F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5: The Stock Option vested in full on January 26, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.10 to $44.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.48 to $46.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The Stock Option vested in full on January 26, 2022.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Decibel Therapeutics, Inc.
Report date September 25, 2023 · Filed September 25, 2023
Section 16 reporting ended · disclosed 2023-09-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-09-25 transaction · row 1
1 source rowRow 1 · 2023-09-25 · Disposition to issuer · Disposed 10,000 · Balance 0 F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), by and among the Issuer, Regeneron Pharmaceuticals, Inc. ("Parent") and Symphony Acquisition Sub, Inc. ("Purchaser"), dated as of August 8, 2023, the shares of common stock, par value $0.001 per share, of the Issuer that were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) were exchanged for (i) $4.00 per share, payable in cash at closing, without interest and subject to reduction for any applicable withholding of taxes (the "Cash Consideration"), plus (ii) one contractual, non-tradeable contingent value right per share (each, a "CVR"), F2: (Continued from Footnote 1) which entitles the holder to potentially receive contingent payments of up to an aggregate of $3.50 per CVR, without interest and subject to reduction for any applicable withholding taxes, upon the achievement of certain specified milestones in accordance with the terms and subject to the conditions of a Contingent Value Rights Agreement (the "CVR Agreement"), dated as of September 25, 2023, by and among Parent, Purchaser, Computershare Inc., and Computershare Trust Company, N.A. In addition, at the effective time of the merger (the "Effective Time"), pursuant to the Merger Agreement, each outstanding restricted stock unit of the Issuer (each a "Company RSU"), whether or not vested, was cancelled and exchanged for the right to receive (i) a cash payment equal to (x) the total numbers of shares subject to such Company RSU multiplied by (y) the Cash Consideration and (ii) one CVR with respect to each share subject to such Company RSU. F3: Includes 10,000 unvested Company RSUs. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.34 · Expires 2033-03-18 | Direct | 0 |
Reported balance
After 2023-09-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-09-25 · Disposition to issuer · Disposed 10,000 · Balance 0 F4: At the Effective Time, pursuant to the Merger Agreement, each outstanding option to purchase shares of common stock of the Issuer having an exercise price per share that was less than the amount of the Cash Consideration (each a "Tranche 1 Option"), was cancelled and exchanged for (A) an amount in cash equal to the product of (x) the total number of shares subject to such Tranche 1 Option immediately prior to the Effective Time multiplied by (y) the excess of the amount of the Cash Consideration over the applicable exercise price per share of such Tranche 1 Option, and (B) one CVR with respect to each share subject to such Tranche 1 Option as of immediately prior to the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), by and among the Issuer, Regeneron Pharmaceuticals, Inc. ("Parent") and Symphony Acquisition Sub, Inc. ("Purchaser"), dated as of August 8, 2023, the shares of common stock, par value $0.001 per share, of the Issuer that were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) were exchanged for (i) $4.00 per share, payable in cash at closing, without interest and subject to reduction for any applicable withholding of taxes (the "Cash Consideration"), plus (ii) one contractual, non-tradeable contingent value right per share (each, a "CVR"),
F2: (Continued from Footnote 1) which entitles the holder to potentially receive contingent payments of up to an aggregate of $3.50 per CVR, without interest and subject to reduction for any applicable withholding taxes, upon the achievement of certain specified milestones in accordance with the terms and subject to the conditions of a Contingent Value Rights Agreement (the "CVR Agreement"), dated as of September 25, 2023, by and among Parent, Purchaser, Computershare Inc., and Computershare Trust Company, N.A. In addition, at the effective time of the merger (the "Effective Time"), pursuant to the Merger Agreement, each outstanding restricted stock unit of the Issuer (each a "Company RSU"), whether or not vested, was cancelled and exchanged for the right to receive (i) a cash payment equal to (x) the total numbers of shares subject to such Company RSU multiplied by (y) the Cash Consideration and (ii) one CVR with respect to each share subject to such Company RSU.
F3: Includes 10,000 unvested Company RSUs.
F4: At the Effective Time, pursuant to the Merger Agreement, each outstanding option to purchase shares of common stock of the Issuer having an exercise price per share that was less than the amount of the Cash Consideration (each a "Tranche 1 Option"), was cancelled and exchanged for (A) an amount in cash equal to the product of (x) the total number of shares subject to such Tranche 1 Option immediately prior to the Effective Time multiplied by (y) the excess of the amount of the Cash Consideration over the applicable exercise price per share of such Tranche 1 Option, and (B) one CVR with respect to each share subject to such Tranche 1 Option as of immediately prior to the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2020 Filed Jan 29, 2020 16:24 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 11,707 | $62.42 | $730,750.94 |
DisclosureSEC source: 0000904454-20-000084 · edgar.xml · nonDerivative · entry 6 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,979 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.73 to $62.72. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 28, 2020 Filed Jan 29, 2020 16:24 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 10,476 | $61.24 | $641,550.24 |
DisclosureSEC source: 0000904454-20-000084 · edgar.xml · nonDerivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,686 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.73 to $61.70. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 16:24 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 600 | $62.44 | $37,464.00 |
DisclosureSEC source: 0000904454-20-000084 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,162 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.39 to $62.49. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 16:24 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 13,106 | $61.86 | $810,737.16 |
DisclosureSEC source: 0000904454-20-000084 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,762 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.38 to $62.37. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 16:24 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 13,207 | $69.94 | $923,697.58 |
DisclosureSEC source: 0000904454-20-000084 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,868 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.37 to $61.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 16:24 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,376 | $59.87 | $82,381.12 |
DisclosureSEC source: 0000904454-20-000084 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,075 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.25 to $60.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:13 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,339 | $0.00 Strike: $7.53 | $0.00 |
DisclosureSEC source: 0000904454-19-000754 · edgar.xml · derivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,661 Underlying: Ordinary Shares · 7,339 shares Expires 2026-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The Stock Option vested 25% on September 29, 2017 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:13 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 276 | $71.70 | $19,789.20 |
DisclosureSEC source: 0000904454-19-000754 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,451 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.685 to $71.750. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:13 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,110 | $70.55 | $78,310.50 |
DisclosureSEC source: 0000904454-19-000754 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,727 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.325 to $71.100. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:13 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 6,154 | $69.94 | $430,410.76 |
DisclosureSEC source: 0000904454-19-000754 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,837 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.325 to $70.320. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:13 UTC | uniQure N.V. QURE · Entity 4162 | Exercise / conversionOrdinary Shares | 7,339 | $7.53 | $55,262.67 |
DisclosureSEC source: 0000904454-19-000754 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 15:12 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,200 | $54.67 | $65,604.00 |
DisclosureSEC source: 0000904454-19-000732 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,652 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.49 to $54.82. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 15:12 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 3,500 | $54.09 | $189,315.00 |
DisclosureSEC source: 0000904454-19-000732 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,852 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.49 to $54.47. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 15:12 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 3,300 | $53.04 | $175,032.00 |
DisclosureSEC source: 0000904454-19-000732 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,352 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.46 to $53.40. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 23, 2019 Filed Oct 25, 2019 12:38 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 3,184 | $43.65 | $138,981.60 |
DisclosureSEC source: 0000904454-19-000689 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,652 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.43 to $43.98. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 23, 2019 Filed Oct 25, 2019 12:38 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 4,816 | $42.94 | $206,799.04 |
DisclosureSEC source: 0000904454-19-000689 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,836 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.43 to $43.42. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 17:49 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 77 | $48.38 | $3,725.26 |
DisclosureSEC source: 0000904454-19-000644 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,652 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 17:49 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,841 | $47.58 | $87,594.78 |
DisclosureSEC source: 0000904454-19-000644 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,729 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.27 to $48.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 17:49 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 3,008 | $46.69 | $140,443.52 |
DisclosureSEC source: 0000904454-19-000644 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,570 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.25 to $47.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 17:49 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 3,074 | $47.73 | $146,722.02 |
DisclosureSEC source: 0000904454-19-000644 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,578 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.20 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: Includes 114 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2019 and 308 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2019. Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 14:43 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 8,000 | $56.48 | $451,840.00 |
DisclosureSEC source: 0000904454-19-000614 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,230 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.10 to $56.98. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 14:37 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 2,500 | $72.70 | $181,750.00 |
DisclosureSEC source: 0000904454-19-000573 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,230 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.40 to $73.33. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 14:37 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 2,109 | $71.98 | $151,805.82 |
DisclosureSEC source: 0000904454-19-000573 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,730 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.57 to $72.27. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 14:37 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,000 | $70.69 | $70,690.00 |
DisclosureSEC source: 0000904454-19-000573 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,839 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.35 to $71.74. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 14:37 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 2,391 | $70.00 | $167,370.00 |
DisclosureSEC source: 0000904454-19-000573 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,839 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.32 to $70.31. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 15:03 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 2,177 | $77.97 | $169,740.69 |
DisclosureSEC source: 0000904454-19-000511 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,230 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.72 to $78.32. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 15:03 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 5,823 | $77.26 | $449,884.98 |
DisclosureSEC source: 0000904454-19-000511 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,407 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.72 to $77.71. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2019 Filed May 17, 2019 19:48 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 306 | $59.17 | $18,106.02 |
DisclosureSEC source: 0000904454-19-000398 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,230 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.10 to $59.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2019 Filed May 17, 2019 19:48 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 6,194 | $58.56 | $362,720.64 |
DisclosureSEC source: 0000904454-19-000398 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,536 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.07 to $59.06. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2019 Filed May 17, 2019 19:48 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,500 | $57.46 | $86,190.00 |
DisclosureSEC source: 0000904454-19-000398 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,730 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.02 to $57.98. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 19:15 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 11,207 | $62.65 | $702,118.55 |
DisclosureSEC source: 0000904454-19-000324 · edgar.xml · nonDerivative · entry 6 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,230 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.08 to $63.06. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 19:15 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 7,395 | $63.57 | $470,100.15 |
DisclosureSEC source: 0000904454-19-000324 · edgar.xml · nonDerivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,437 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.08 to $64.07. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 19:15 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 1,086 | $64.33 | $69,862.38 |
DisclosureSEC source: 0000904454-19-000324 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,832 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.08 to $64.79. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 19:15 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 17,940 | $63.75 | $1,143,675.00 |
DisclosureSEC source: 0000904454-19-000324 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,918 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.22 to $64.21. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 19:15 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 28,848 | $64.64 | $1,864,734.72 |
DisclosureSEC source: 0000904454-19-000324 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,858 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.22 to $65.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 19:15 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 900 | $65.34 | $58,806.00 |
DisclosureSEC source: 0000904454-19-000324 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,706 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.23 to $65.52. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 578 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2019. Read SEC document |
| January 28, 2019 Filed Jan 31, 2019 00:15 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 19,085 | $31.42 | $599,650.70 |
DisclosureSEC source: 0000904454-19-000136 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,028 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F1 · shares: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.01 to $31.81. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 25, 2019 Filed Jan 30, 2019 00:07 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 83,362 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-19-000098 · edgar.xml · derivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,362 Underlying: Ordinary Shares · 83,362 shares Expires 2029-01-25 F3 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| January 25, 2019 Filed Jan 30, 2019 00:07 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 43,924 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000098 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509,113 F2 · shares: Represents performance-based restricted share units ("PRSUs") granted on January 26, 2018 to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated, which vested on January 25, 2019. Each PRSU represents the contingent right to receive one Ordinary Share. Read SEC document |
| January 25, 2019 Filed Jan 30, 2019 00:07 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 25,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000098 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,189 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 19:35 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 39,169 | $21.72 | $850,750.68 |
DisclosureSEC source: 0000904454-18-000239 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,764 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F1 · shares: As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.50 to $22.19. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 16:39 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 83,663 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-18-000074 · edgar.xml · derivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,663 Underlying: Ordinary Shares · 83,663 shares Expires 2028-01-26 F2 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 16:39 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 31,374 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-18-000074 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478,933 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| January 04, 2018 Filed Jan 5, 2018 21:40 UTC | uniQure N.V. QURE · Entity 4162 | SaleOrdinary Shares | 21,690 | $19.87 | $431,069.23 |
DisclosureSEC source: 0001209191-18-002472 · doc4.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,559 F1 · kind: As required by the relevant Restricted Share Unit Agreement, the reporting person sold the ordinary shares and remitted the proceeds therefrom to the issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.73 to $20.15, inclusive. The reporting person undertakes to provide uniQure N.V., any security holder of uniQure N.V. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price ranges set forth in this footnote. F3 · balance_after: Consists of (i) 209,625 performance share units that vest in full on January 27, 2020 (ii) 39,870 ordinary shares, (iii) 23,064 performance share units previously disclosed by the reporting person on Table II that vest in full on January 27, 2019 and (iv) 175,000 restricted share units previously disclosed by the reporting person on Table II, that vest 50% on March 14, 2019 and 50% on March 15, 2019. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:36 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 61,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065950 · doc4.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,185 F2 · date: On September 29, 2016, the uniQure Board of Directors approved a grant to Mr. Kapusta of 61,560 performance share units linked to the achievement of specified performance goals in 2017. On December 13, 2017, the Board of Directors determined that certain performance goals were met. Following the Board's determination, each performance share unit represents the right to receive one ordinary share, and will vest in full on December 31, 2017. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:36 UTC | uniQure N.V. QURE · Entity 4162 | GrantOrdinary Shares | 209,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065950 · doc4.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,625 F1 · date: On January 27, 2017, the uniQure Board of Directors approved a grant to Mr. Kapusta of 162,500 performance share units linked to the achievement of specified performance goals in 2017. On December 13, 2017, the Board of Directors determined that certain performance goals were met. Following the Board's determination, each performance share unit represents the right to receive one ordinary share, and will vest in full on January 27, 2020. Read SEC document |
| May 09, 2017 Filed May 10, 2017 13:59 UTC | uniQure N.V. QURE · Entity 4162 | GrantRestricted Stock Unit · Derivative | 175,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019229 · doc1.xml · derivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Ordinary Shares · 175,000 shares Expires not disclosed F2 · derivative.exercise_date: The Restricted Stock Units vest 50% on March 14, 2018 and 50% on March 14, 2019, if the Reporting Person continues to be employed by the Issuer or a subsidiary of the Issuer employing the Reporting Person through and including said dates. F3 · derivative.expiration_date: Expiration date is not applicable as the vested Restricted Stock Units shall be settled on the first business day following the date that such Restricted Stock Units vests. Read SEC document |
| May 09, 2017 Filed May 10, 2017 13:59 UTC | uniQure N.V. QURE · Entity 4162 | GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $6.22 | $0.00 |
DisclosureSEC source: 0001140361-17-019229 · doc1.xml · derivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Ordinary Shares · 175,000 shares Expires 2027-03-14 F1 · derivative.exercise_date: The Stock Option vests 25% on March 14, 2018 and 6.25% quarterly thereafter until fully vested. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 20:19 UTC | uniQure N.V. QURE · Entity 4162 | GrantPerformance Share Units · Derivative | 162,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-003709 · doc1.xml · derivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,124 Underlying: Ordinary Shares · 162,500 shares Expires not disclosed F1 · derivative.exercise_date: Performance Shares Units of a maximum of 162,500 shares of the Company's Ordinary Shares were granted on January 27, 2017. The Board of Directors shall determine how many Performance Share Units are to be granted in conjunction with a review of certain performance goals associated with the grant. Any such Performance Share Units granted by the Board of Directors shall vest 100% on January 27, 2020. F2 · derivative.expiration_date: Expiration date is not applicable. Read SEC document |
| January 27, 2017 Filed Mar 3, 2017 16:25 UTC | uniQure N.V. QURE · Entity 4162 | GrantPerformance Share Units · Derivative | 162,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-010423 · doc1.xml · derivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, CFO, Managing Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,124 Underlying: Ordinary Shares · 162,500 shares Expires not disclosed F1 · derivative.exercise_date: Performance Shares Units of a maximum of 162,500 shares of the Company's Ordinary Shares were granted on January 27, 2017. The Board of Directors shall determine how many Performance Share Units are to be granted in conjunction with a review of certain performance goals associated with the grant. Any such Performance Share Units granted by the Board of Directors shall vest 100% on January 27, 2020. F2 · derivative.expiration_date: Expiration date is not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.